Menu Search
Equities

Novo Nordisk A/S

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NOVA:MUN

Novo Nordisk A/S

Actions
  • Price (EUR)41.35
  • Today's Change0.05 / 0.12%
  • Shares traded200.00
  • 1 Year change-45.16%
  • Beta0.7022
Data delayed at least 15 minutes, as of Feb 17 2026 07:13 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in DKKIncome statement in DKKView more

Year on year Novo Nordisk A/S had little change in net income (from 100.99bn to 102.43bn) despite revenues that grew 6.43% from 290.40bn to 309.06bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 15.00% to 17.15%.
Gross margin80.98%
Net profit margin33.14%
Operating margin41.30%
Return on assets20.31%
Return on equity60.70%
Return on investment35.60%
More ▼

Cash flow in DKKView more

In 2025, Novo Nordisk A/S increased its cash reserves by 69.05%, or 10.81bn. The company earned 119.10bn from its operations for a Cash Flow Margin of 38.54%. In addition the company used 79.16bn on investing activities and also paid 28.41bn in financing cash flows.
Cash flow per share4.42
Price/Cash flow per share8.41
Book value per share6.93
Tangible book value per share2.28
More ▼

Balance sheet in DKKView more

Novo Nordisk A/S has a Debt to Total Capital ratio of 40.29%, a lower figure than the previous year's 62.50%.
Current ratio0.7997
Quick ratio0.5696
Total debt/total equity0.6749
Total debt/total capital0.4029
More ▼

Growth rates in DKK

SmartText is unavailable
Div yield(5 year avg)1.79%
Div growth rate (5 year)21.94%
Payout ratio (TTM)50.74%
EPS growth(5 years)20.66
EPS (TTM) vs
TTM 1 year ago		1.76
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.